300451 B-Soft Co.,Ltd.
- 4.29
- -0.05-1.15%
B-Soft Co.,Ltd. News
Chuangye Huikang (300451.SZ) announced first-quarter results, net profit of 12.3597 million yuan, an increase of 19.03% over the previous year
Chuangye Huikang (300451.SZ) released its report for the first quarter of 2024. The company achieved operating revenue during the period...
Some Investors May Be Willing To Look Past B-SOFTLtd's (SZSE:300451) Soft Earnings
The most recent earnings report from B-SOFT Co.,Ltd. (SZSE:300451) was disappointing for shareholders. While the headline numbers were soft, we believe that investors might be missing some encouragin
B-SOFT Co.,Ltd. (SZSE:300451) Analysts Are Reducing Their Forecasts For This Year
The latest analyst coverage could presage a bad day for B-SOFT Co.,Ltd. (SZSE:300451), with the analysts making across-the-board cuts to their statutory estimates that might leave shareholders a littl
Take Care Before Jumping Onto B-SOFT Co.,Ltd. (SZSE:300451) Even Though It's 26% Cheaper
To the annoyance of some shareholders, B-SOFT Co.,Ltd. (SZSE:300451) shares are down a considerable 26% in the last month, which continues a horrid run for the company. The recent drop completes a
B-SOFT Co.,Ltd. Just Missed EPS By 90%: Here's What Analysts Think Will Happen Next
B-SOFT Co.,Ltd. (SZSE:300451) just released its latest yearly report and things are not looking great. It wasn't a great result overall - while revenue fell marginally short of analyst estimates
Chuangye Huikang (300451.SZ): 2023 net profit of 366.885 million yuan, plans to distribute 10 to 0.1 yuan
Gelonghui, April 12: Chuanghui Huikang (300451.SZ) announced its 2023 annual report. In 2023, the company achieved operating income of 1,616 billion yuan, an increase of 5.81%; net profit attributable to shareholders of listed companies was 36.6885 million yuan, a year-on-year decrease of 13.93%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 33.9954 million yuan, a year-on-year decrease of 27.44%; basic income per share was 0.02 yuan; it is intended to distribute a cash dividend of 0.1 yuan (tax included) to all shareholders for every 10 shares.
B-SOFTLtd (SZSE:300451 Shareholders Incur Further Losses as Stock Declines 5.6% This Week, Taking One-year Losses to 54%
Investing in stocks comes with the risk that the share price will fall. Unfortunately, shareholders of B-SOFT Co.,Ltd. (SZSE:300451) have suffered share price declines over the last year. To wit the
Chuangye Huikang (300451.SZ): At present, the company's medical device sales business has generated revenue contributions
Gelonghui March 11 丨 An investor asked Chuangye Huikang (300451.SZ) on the investor interactive platform, “Has the company's medical device sales business currently generated revenue? How much impact will it have on the performance growth of listed companies?” The company replied that at present, the company's medical device sales business has generated revenue contributions. For details on the impact on performance, please refer to the disclosure in the company's regular reports.
The Returns On Capital At B-SOFTLtd (SZSE:300451) Don't Inspire Confidence
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is to try and find a company with returns on capital employed (ROCE) that are increa
Chuangye Huikang (300451.SZ): The performance of new orders in the first quarter was good, and there are currently sufficient orders in hand
Gelonghui March 5 | Chuangye Huikang (300451.SZ) said on the investor interactive platform that the company performed well in new orders in the first quarter, and the company currently has sufficient orders in hand.
Venture Huikang (300451.SZ): “Huikang-Qizhen Medical Model” has been successfully piloted in many of the top three hospitals and regions in Zhejiang Province
Gelonghui, Feb. 20 | Venture Huikang (300451.SZ) said on the investor interactive platform that the “Huikang-Qizhen Medical Model” was authorized by Zhejiang University and carried out model training and fine-tuning through its medical knowledge base, and has now achieved a data training scale of 6B (6 billion) to 13B (13 billion). The model can provide offline and online deployment methods for different product scenarios. At present, the training data volume of the Huikang-Qizhen model has reached more than 130,000 drug knowledge and drug instructions, more than 10,000 disease knowledge, more than 20,000 guidance documents, and more than 4,000 surgical knowledge
Investors Give B-SOFT Co.,Ltd. (SZSE:300451) Shares A 28% Hiding
To the annoyance of some shareholders, B-SOFT Co.,Ltd. (SZSE:300451) shares are down a considerable 28% in the last month, which continues a horrid run for the company. For any long-term shareholde
Here's Why B-SOFTLtd (SZSE:300451) Can Manage Its Debt Responsibly
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
B-SOFT Co.,Ltd.'s (SZSE:300451) Market Cap Dropped CN¥541m Last Week; Individual Investors Who Hold 43% Were Hit as Were Institutions
Key Insights The considerable ownership by individual investors in B-SOFTLtd indicates that they collectively have a greater say in management and business strategy A total of 16 investors have a ma
Venture Huikang (300451.SZ): Medical devices sold in cooperation with Philips mainly refer to clinical and intelligent devices in the field of Philips healthcare technology
Gelonghui, January 12丨An investor asked Venture Huikang (300451.SZ) on the investor interactive platform, “How is the company's market space and profit as a sales and agent for Philips medical devices? What are the specific advantages of CTAsy1.0 software compared to the same industry?” The company replied that the medical devices sold by the company in cooperation with Philips mainly refer to clinical and intelligent devices in the field of Philips healthcare technology. For this reason, the company has obtained a license to operate Class III medical devices (the highest class of medical devices). As the world's leading manufacturer of medical devices, Philips has advanced technology
Venture Wellcome (300451.SZ): The localization development of the CTAsy1.0 core system, a “next-generation EMR software product” in collaboration with Philips, is nearing completion
Gelonghui, January 11丨An investor asked Venture Huikang (300451.SZ) on the investor interactive platform, “When will the cooperation between the company and Philips produce results?” The company replied that the localization development of the CTAsy1.0 core system, a “next-generation EMR software product” in cooperation with Philips, is nearing completion, and pilot projects are already underway. At present, CTAsy1.0 has basically completed the established R&D goals, and will be officially released later. According to the cooperation agreement between the two parties, after CTAsy1.0 is officially released, the cooperation between the two parties will enter the marketing and sales stage, and Philips will be C
Investors Still Waiting For A Pull Back In B-SOFT Co.,Ltd. (SZSE:300451)
It's not a stretch to say that B-SOFT Co.,Ltd.'s (SZSE:300451) price-to-sales (or "P/S") ratio of 6.4x right now seems quite "middle-of-the-road" for companies in the Healthcare Services industry in
B-SOFTLtd (SZSE:300451 Investor Three-year Losses Grow to 35% as the Stock Sheds CN¥386m This Past Week
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But its virtually certain that sometimes you will buy stocks that fall
B-SOFTLtd (SZSE:300451) May Have Issues Allocating Its Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach is to try and find a company with returns on capital employed (ROCE) that are inc
[BT Financial Report Instantaneous Analysis] Entrepreneurship Huikang 2023 Three-Quarter Report: Balance Ratio Declines, Net Profit Is Under Pressure
This financial report announcement time: 2023-10-25 16:16:33 Chuangye Huikang Technology Co., Ltd. (stock code: 300451) is an enterprise focusing on medical and health informatization. Their products cover various smart scenarios such as smart medicine, smart health, medical insurance, health, and old-age care. Since the launch of the “Huikang Cloud” overall cloud transformation and development strategy in 2021, the startup Huikang has transformed from a traditional IT information product service provider to a technology cloud ecosystem enterprise, becoming an outstanding leader in healthy China. Judging from the financial data for the third quarter of 2023, the total assets of the startup Huikang are 57.5
Analysis
Price Target
No Data
